TRELEVANT Trademark

Trademark Overview

On Tuesday, March 6, 2012, a trademark application was filed for TRELEVANT with the United States Patent and Trademark Office. The USPTO has given the TRELEVANT trademark a serial number of 85561475. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 5, 2015. This trademark is owned by Glaxo Group Limited. The TRELEVANT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
trelevant

General Information

Serial Number85561475
Word MarkTRELEVANT
Filing DateTuesday, March 6, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 5, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 10, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording TRELEVANT has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 12, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, October 5, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 5, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 11, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 10, 2015EXTENSION 5 GRANTED
Monday, March 2, 2015EXTENSION 5 FILED
Monday, March 2, 2015TEAS EXTENSION RECEIVED
Wednesday, September 3, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 2, 2014EXTENSION 4 GRANTED
Thursday, August 28, 2014EXTENSION 4 FILED
Thursday, August 28, 2014TEAS EXTENSION RECEIVED
Saturday, March 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 7, 2014EXTENSION 3 GRANTED
Tuesday, February 25, 2014EXTENSION 3 FILED
Tuesday, February 25, 2014TEAS EXTENSION RECEIVED
Thursday, September 19, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 18, 2013EXTENSION 2 GRANTED
Wednesday, August 14, 2013EXTENSION 2 FILED
Friday, September 13, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 14, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 15, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 13, 2013EXTENSION 1 GRANTED
Wednesday, February 13, 2013EXTENSION 1 FILED
Wednesday, February 13, 2013TEAS EXTENSION RECEIVED
Tuesday, September 4, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 10, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 10, 2012PUBLISHED FOR OPPOSITION
Wednesday, June 20, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 5, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 5, 2012ASSIGNED TO EXAMINER
Monday, March 12, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 9, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

trelevant pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological